Detalhe da pesquisa
1.
Augmented Lipocalin-2 Is Associated with Chronic Obstructive Pulmonary Disease and Counteracts Lung Adenocarcinoma Development.
Am J Respir Crit Care Med
; 203(1): 90-101, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32730093
2.
Sox2 regulates the emergence of lung basal cells by directly activating the transcription of Trp63.
Am J Respir Cell Mol Biol
; 51(2): 311-22, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24669837
3.
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance.
Front Immunol
; 14: 1161869, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449205
4.
Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers.
Nat Commun
; 12(1): 2606, 2021 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972557
5.
Targeting CDK4 overcomes EMT-mediated tumor heterogeneity and therapeutic resistance in KRAS-mutant lung cancer.
JCI Insight
; 6(17)2021 09 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309585
6.
Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC.
Cancer Res
; 81(5): 1398-1412, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33402388
7.
Next-Generation Immunotherapies to Improve Anticancer Immunity.
Front Pharmacol
; 11: 566401, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33505304